Single variable domain-IgG fusion. A novel recombinant approach to Fc domain-containing bispecific antibodies.
about
An alternative chemical redox method for the production of bispecific antibodies: implication in rapid detection of food borne pathogensA novel redox method for rapid production of functional bi-specific antibodies for use in early pilot studiesAdvances in Antibody DesignThe breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency.Cross-Neutralising Nanobodies Bind to a Conserved Pocket in the Hemagglutinin Stem Region Identified Using Yeast Display and Deep Mutational Scanning.Multiple signaling pathways induced by hexavalent, monospecific, anti-CD20 and hexavalent, bispecific, anti-CD20/CD22 humanized antibodies correlate with enhanced toxicity to B-cell lymphomas and leukemiasInterleukin-15:Interleukin-15 receptor α scaffold for creation of multivalent targeted immune moleculesSimultaneous targeting of two ligand-binding sites on VEGFR2 using biparatopic Affibody molecules results in dramatically improved affinity.Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. Properties of anti-CD20/CD22 antibodies in lymphoma.Antibody light chain variable domains and their biophysically improved versions for human immunotherapy.Implication of platelet-derived growth factor receptor alpha in prostate cancer skeletal metastasisDual targeting strategies with bispecific antibodies.Design and Validation of a Novel Generic Platform for the Production of Tetravalent IgG1-like Bispecific Antibodies.Construction and characterization of VL-VH tail-parallel genetically engineered antibodies against staphylococcal enterotoxins.A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens.The making of bispecific antibodiesSEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies.
P2860
Q28540976-BC1C0792-4AAF-42DF-A958-D974D7AE6D64Q28742330-B1654DAD-B4C3-4710-8244-18B75051DDDDQ28817608-07498B74-FDDB-4FD7-9058-04BD663B7FF1Q30365366-95973577-F511-4DCB-A946-32C0F8823EE7Q30394097-53B40CC4-5FA3-4951-974E-F69475A35996Q34369841-E7122873-123D-4A94-939B-EF6EA461431BQ34626998-6A373313-1FC2-4D6B-A673-9C7CA1B7D40CQ35525772-24C626D6-88C0-43AC-9B16-5B9E3773AD97Q37234627-57D90171-D9B2-400F-A461-F92E803C46E7Q37593692-360A1D58-1C7F-46C5-8A85-4A4A41FF86EBQ37924342-475AC41A-0235-487C-928E-E615C4637D81Q37997559-C8A99B5C-0EF1-4A80-9D69-7BE12230809EQ38790644-FD1D2004-3905-4F59-B3E4-FEDEC96684D3Q38917863-69CB8B5B-78AA-404E-BC0D-F9B6E8433372Q39917871-A2EC4967-0052-431E-980B-492AF3112307Q42323236-E09A2CF8-4CA0-498E-9113-55CD6105A262Q46702724-954EDEA5-34F3-429A-B02E-899D86427E71
P2860
Single variable domain-IgG fusion. A novel recombinant approach to Fc domain-containing bispecific antibodies.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Single variable domain-IgG fus ...... taining bispecific antibodies.
@ast
Single variable domain-IgG fus ...... taining bispecific antibodies.
@en
type
label
Single variable domain-IgG fus ...... taining bispecific antibodies.
@ast
Single variable domain-IgG fus ...... taining bispecific antibodies.
@en
prefLabel
Single variable domain-IgG fus ...... taining bispecific antibodies.
@ast
Single variable domain-IgG fus ...... taining bispecific antibodies.
@en
P2093
P2860
P356
P1476
Single variable domain-IgG fus ...... taining bispecific antibodies.
@en
P2093
Haifan Zhang
Juqun Shen
Marie Danielle Vil
Michelle Iacolina
Xenia Jimenez
Zhenping Zhu
P2860
P304
10706-10714
P356
10.1074/JBC.M513415200
P407
P577
2006-02-15T00:00:00Z